DR info

Clinical trials : 5 / Drugs : 6 - (DrugBank : 6) / Drug target genes : 8 - Drug target pathways : 12

Tricuspid atresia and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)

ID	Diseases (Sorted by score)	Score
212	Tricuspid atresia	-
13	Multiple sclerosis/Neuromyelitis optica	8.000
78	Hypopituitarism	4.705
210	Single Ventricle	3.418
323	Aromatic L-amino acid decarboxylase deficiency	3.000
211	Hypoplastic left heart syndrome	2.250
21	Mitochondrial disease	2.170
90	Retinitis pigmentosa	2.163
113	Muscular dystrophy	2.136
226	Interstitial cystitis with Hunners ulcer	2.125
96	Crohn disease	2.048
2	Amyotrophic lateral sclerosis	2.047
46	Malignant rheumatoid arthritis	2.043
6	Parkinson disease	2.043
139	Congenital cerebral hypomyelination	2.000
118	Myelomeningocele	1.828
169	Menkes disease	1.750
170	Occipital horn syndrome	1.750
280	Huge arteriovenous malformation with cervicofacial or limb lesion	1.527
80	Resistance to thyroid hormone	1.500
215	Tetralogy of Fallot	1.438
288	Autoimmune acquired coagulation factor deficiency	1.438
4	Primary lateral sclerosis	1.421
254	Porphyria	1.421
22	Moyamoya disease	1.326
11	Myasthenia gravis	1.250
107	Juvenile idiopathic arthritis	1.233
206	Fragile X syndrome	1.229
17	Multiple system atrophy	1.217
222	Primary nephrotic syndrome	1.217
5	Progressive supranuclear palsy	1.212
70	Spinal stenosis	1.210
84	Sarcoidosis	1.194
8	Huntington disease	1.192
34	Neurofibromatosis	1.190
65	Primary immunodeficiency	1.188
85	Idiopathic interstitial pneumonia	1.182
86	Pulmonary arterial hypertension	1.181
51	Scleroderma	1.175
49	Systemic lupus erythematosus	1.174
47	Buerger disease	1.000